Literature DB >> 10682977

The human leukocyte antigen complex and chronic ocular inflammatory disorders.

M P Davey1, J T Rosenbaum.   

Abstract

PURPOSE: To review the role of gene products from the human leukocyte antigen (HLA) complex in the normal functioning of the immune system, ocular inflammation, and models of autoimmunity.
METHOD: A review of recently published reports.
RESULTS: Many chronic ocular inflammatory diseases are associated with specific alleles of the HLA complex. Understanding how HLA gene products function normally provides clues to the mechanism of disease associations. In the thymus, these molecules control the shape of the developing T-cell repertoire, leading to self-tolerance. In the periphery, HLA molecules bind and present peptide fragments to T cells, leading to a variety of effector functions. Although effector functions are for the most part beneficial, models are reviewed in which peptide-HLA interactions lead to T-cell responses with pathologic consequences. Herpes stromal keratitis is an informative animal model highlighting the role of self-tolerance, infection, and molecular mimicry in the development of autoimmunity.
CONCLUSIONS: Human leukocyte antigen gene products may be associated with chronic inflammatory disorders through the unique presentation of "disease-inducing" peptides or the development of a T-cell repertoire prone to autoreactivity and molecular mimicry.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10682977     DOI: 10.1016/s0002-9394(99)00433-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  A promising therapeutic approach for treatment of posterior uveitis: recombinant T cell receptor ligand protects Lewis rats from acute and recurrent experimental autoimmune uveitis.

Authors:  Grazyna Adamus; Landon J Karren; Jeff Mooney; Gregory G Burrows
Journal:  Ophthalmic Res       Date:  2010-02-08       Impact factor: 2.892

2.  Aldose reductase deficiency protects from autoimmune- and endotoxin-induced uveitis in mice.

Authors:  Umesh C S Yadav; Mohammed Shoeb; Satish K Srivastava; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-17       Impact factor: 4.799

3.  Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients.

Authors:  D J Kilmartin; D Wilson; J Liversidge; A D Dick; J Bruce; R W Acheson; S J Urbaniak; J V Forrester
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

Review 4.  Recent Advances in Age-Related Macular Degeneration Therapies.

Authors:  Marie Fabre; Lou Mateo; Diana Lamaa; Stéphanie Baillif; Gilles Pagès; Luc Demange; Cyril Ronco; Rachid Benhida
Journal:  Molecules       Date:  2022-08-10       Impact factor: 4.927

5.  Retrospective study on the effects of immunosuppressive therapy in uveitis associated with rheumatic diseases in Korea.

Authors:  Sang Yeob Lee; Won Tae Chung; Woo Jin Jung; Sung Won Lee
Journal:  Rheumatol Int       Date:  2011-12-24       Impact factor: 2.631

6.  EnRAPtured: Is Endoplasmic Reticulum Aminopeptidase a New Clue to the Pathogenesis and ThERAPy of Uveitis?

Authors:  James T Rosenbaum; Tejpal Gill; Tammy M Martin
Journal:  Ophthalmol Sci       Date:  2021-09-13

7.  Effective Arrestin-Specific Immunotherapy of Experimental Autoimmune Uveitis with RTL: A Prospect for Treatment of Human Uveitis.

Authors:  Madison Kyger; Aneta Worley; Jianya Huan; Hugh McDowell; W Clay Smith; Gregory G Burrows; Mary J Mattapallil; Rachel R Caspi; Grazyna Adamus
Journal:  Transl Vis Sci Technol       Date:  2013-02-05       Impact factor: 3.283

Review 8.  Immunotherapeutic strategies in autoimmune uveitis.

Authors:  Pedro Henrique Papotto; Eliana Blini Marengo; Luiz Roberto Sardinha; Anna Carla Goldberg; Luiz Vicente Rizzo
Journal:  Autoimmun Rev       Date:  2014-05-12       Impact factor: 9.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.